Utilising routine clinical laboratory data to support quality improvement in health care: Application of a national acute kidney injury alert system as a proof of concept

被引:0
|
作者
Holmes, Jennifer [1 ,4 ]
Higginson, Ray [1 ]
Geen, John [1 ,2 ]
Phillips, Aled [3 ]
机构
[1] Univ South Wales, Fac Life Sci & Educ, Pontypridd, Wales
[2] Cwm TafMorgannwg Univ Hlth Board, Prince Charles Hosp, Dept Clin Biochem, Merthyr, Wales
[3] Cardiff Univ, Inst Nephrol, Cardiff, Wales
[4] Univ South Wales, Fac Life Sci & Educ, Pontypridd CF37 1DL, Wales
关键词
Acute kidney injury; serum creatinine; statistical process control; quality improvement; value-based health care; outcomes; INDICATORS; AKI;
D O I
10.1177/00045632231216593
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Acute kidney injury (AKI) is a global health issue known to cause avoidable harm and death. Improvement in its prevention and management is therefore considered an important goal for the health-care sector. The work here aimed to develop a tool which could be used to robustly and reliably measure, monitor, and compare the effectiveness of health-care interventions related to AKI across the Welsh NHS, a mechanism which did not exist previously. Methods: Using serum creatinine (SCr) as a biomarker for AKI and a validated national data-set collected from the all Wales Laboratory Information Management System, work involved applying Donabedian's framework to develop indicators with which to measure outcomes related to AKI, and exploring the potential of statistical process control (SPC) techniques for analysing data on these indicators. Results: Rate of AKI incidence and 30-day AKI-associated mortality are proposed as valid, feasible indicators with which to measure the effectiveness of health-care interventions related to AKI. The control chart, funnel plot, and Pareto chart are proposed as appropriate, robust SPC techniques to analyse and visualise variation in AKI-related outcomes. Conclusions: This work demonstrates that routinely collected large SCr data offer a significant opportunity to monitor and therefore inform improvement in patient outcomes related to AKI. Moreover, while this work concerns utilisation of SCr data for improvement in AKI strategies, it is a proof of concept which could be replicated for other routinely collected clinical laboratory data, to improve the prevention and/or management of the conditions to which they relate.
引用
收藏
页码:218 / 229
页数:12
相关论文
共 20 条